Published in Dermatoendocrinol on January 01, 2011
Sensing the environment: regulation of local and global homeostasis by the skin's neuroendocrine system. Adv Anat Embryol Cell Biol (2012) 2.99
Key role of CRF in the skin stress response system. Endocr Rev (2013) 1.77
Quantifying long-term stress in brown bears with the hair cortisol concentration: a biomarker that may be confounded by rapid changes in response to capture and handling. Conserv Physiol (2014) 0.84
Hypothalamic-pituitary-thyroid axis hormones stimulate mitochondrial function and biogenesis in human hair follicles. J Invest Dermatol (2013) 0.82
Immunophenotypic characterization of lymphoid cell infiltrates in vitiligo. Clin Exp Immunol (2013) 0.78
Tumour necrosis factor alpha, interferon gamma and substance P are novel modulators of extrapituitary prolactin expression in human skin. PLoS One (2013) 0.76
Bioactive forms of vitamin D selectively stimulate the skin analog of the hypothalamus-pituitary-adrenal axis in human epidermal keratinocytes. Mol Cell Endocrinol (2016) 0.75
Disease Severity, Quality of Life, and Psychiatric Morbidity in Patients With Psoriasis With Reference to Sociodemographic, Lifestyle, and Clinical Variables: A Prospective, Cross-Sectional Study From Lahore, Pakistan. Prim Care Companion CNS Disord (2015) 0.75
Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science (1981) 9.64
The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med (1995) 6.17
Melanin pigmentation in mammalian skin and its hormonal regulation. Physiol Rev (2004) 5.89
Neuroendocrinology of the skin. Endocr Rev (2000) 3.34
Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol Rev (2000) 2.98
Tryptophan hydroxylase-2 controls brain serotonin synthesis. Science (2004) 2.64
TSH receptor and thyroid-specific gene expression in human skin. J Invest Dermatol (2010) 2.50
A novel pathway for sequential transformation of 7-dehydrocholesterol and expression of the P450scc system in mammalian skin. Eur J Biochem (2004) 2.42
Human hair follicles display a functional equivalent of the hypothalamic-pituitary-adrenal axis and synthesize cortisol. FASEB J (2005) 2.23
The cytochrome P450scc system opens an alternate pathway of vitamin D3 metabolism. FEBS J (2005) 2.12
Critical role of mast cells in inflammatory diseases and the effect of acute stress. J Neuroimmunol (2004) 1.98
20-Hydroxyvitamin D3, a product of vitamin D3 hydroxylation by cytochrome P450scc, stimulates keratinocyte differentiation. J Invest Dermatol (2008) 1.91
Melanogenesis is coupled to murine anagen: toward new concepts for the role of melanocytes and the regulation of melanogenesis in hair growth. J Invest Dermatol (1993) 1.88
Hair follicle pigmentation. J Invest Dermatol (2005) 1.84
Pathways and products for the metabolism of vitamin D3 by cytochrome P450scc. FEBS J (2008) 1.84
Products of vitamin D3 or 7-dehydrocholesterol metabolism by cytochrome P450scc show anti-leukemia effects, having low or absent calcemic activity. PLoS One (2010) 1.83
The cutaneous serotoninergic/melatoninergic system: securing a place under the sun. FASEB J (2005) 1.77
An alternative pathway of vitamin D metabolism. Cytochrome P450scc (CYP11A1)-mediated conversion to 20-hydroxyvitamin D2 and 17,20-dihydroxyvitamin D2. FEBS J (2006) 1.75
Cutaneous expression of corticotropin-releasing hormone (CRH), urocortin, and CRH receptors. FASEB J (2001) 1.74
Proopiomelanocortin processing in the pituitary, central nervous system, and peripheral tissues. Endocr Rev (1988) 1.73
Differential expression of HPA axis homolog in the skin. Mol Cell Endocrinol (2006) 1.72
Neuroimmunology of stress: skin takes center stage. J Invest Dermatol (2006) 1.72
Vitamin D: evolutionary, physiological and health perspectives. Curr Drug Targets (2011) 1.69
Gastrointestinal melatonin: localization, function, and clinical relevance. Dig Dis Sci (2002) 1.67
Leptin and hyperleptinemia - from friend to foe for cardiovascular function. J Endocrinol (2004) 1.67
20-Hydroxycholecalciferol, product of vitamin D3 hydroxylation by P450scc, decreases NF-kappaB activity by increasing IkappaB alpha levels in human keratinocytes. PLoS One (2009) 1.65
CRH stimulation of corticosteroids production in melanocytes is mediated by ACTH. Am J Physiol Endocrinol Metab (2004) 1.64
Alternative splicing of CRH-R1 receptors in human and mouse skin: identification of new variants and their differential expression. FASEB J (2001) 1.59
Natural melatonin 'knockdown' in C57BL/6J mice: rare mechanism truncates serotonin N-acetyltransferase. Brain Res Mol Brain Res (1998) 1.58
Melanocytes as "sensory" and regulatory cells in the epidermis. J Theor Biol (1993) 1.55
Sequential metabolism of 7-dehydrocholesterol to steroidal 5,7-dienes in adrenal glands and its biological implication in the skin. PLoS One (2009) 1.52
Mast cells as targets of corticotropin-releasing factor and related peptides. Trends Pharmacol Sci (2004) 1.50
Differential expression of a cutaneous corticotropin-releasing hormone system. Endocrinology (2003) 1.46
Corticotropin releasing hormone and the skin. Front Biosci (2006) 1.45
CRH stimulates POMC activity and corticosterone production in dermal fibroblasts. J Neuroimmunol (2005) 1.42
ACTH receptor, CYP11A1, CYP17 and CYP21A2 genes are expressed in skin. J Clin Endocrinol Metab (1996) 1.41
Functional activity of serotoninergic and melatoninergic systems expressed in the skin. J Cell Physiol (2003) 1.41
CRH functions as a growth factor/cytokine in the skin. J Cell Physiol (2006) 1.38
Enzymatic metabolism of ergosterol by cytochrome p450scc to biologically active 17alpha,24-dihydroxyergosterol. Chem Biol (2005) 1.36
Serotoninergic and melatoninergic systems are fully expressed in human skin. FASEB J (2002) 1.33
Constitutive and UV-induced metabolism of melatonin in keratinocytes and cell-free systems. FASEB J (2006) 1.29
Proopiomelanocortin-derived peptides are synthesized and released by human keratinocytes. J Clin Invest (1994) 1.29
Photo-conversion of two epimers (20R and 20S) of pregna-5,7-diene-3beta, 17alpha, 20-triol and their bioactivity in melanoma cells. Steroids (2008) 1.24
Neuroendocrine system of the skin. Dermatology (2005) 1.24
Molecular and functional characterization of novel CRFR1 isoforms from the skin. Eur J Biochem (2004) 1.22
Corticotropin-releasing hormone: an autocrine hormone that promotes lipogenesis in human sebocytes. Proc Natl Acad Sci U S A (2002) 1.22
Melatonin in the skin: synthesis, metabolism and functions. Trends Endocrinol Metab (2007) 1.20
Skin as an endocrine organ: implications for its function. Drug Discov Today Dis Mech (2008) 1.19
Cutaneous expression of CRH and CRH-R. Is there a "skin stress response system?". Ann N Y Acad Sci (1999) 1.18
Metabolism of progesterone to DOC, corticosterone and 18OHDOC in cultured human melanoma cells. FEBS Lett (1999) 1.17
Active steroidogenesis in the normal rat skin. Biochim Biophys Acta (2000) 1.17
Metabolism of 1alpha-hydroxyvitamin D3 by cytochrome P450scc to biologically active 1alpha,20-dihydroxyvitamin D3. J Steroid Biochem Mol Biol (2008) 1.17
Regulated proenkephalin expression in human skin and cultured skin cells. J Invest Dermatol (2010) 1.17
A nervous breakdown in the skin: stress and the epidermal barrier. J Clin Invest (2007) 1.16
Characterization of a ultraviolet B-induced corticotropin-releasing hormone-proopiomelanocortin system in human melanocytes. Mol Endocrinol (2006) 1.16
Corticotropin-releasing hormone induces keratinocyte differentiation in the adult human epidermis. J Cell Physiol (2005) 1.14
Potential mechanism of skin response to stress. Int J Dermatol (1996) 1.13
Neuroendocrine activity of the melanocyte. Exp Dermatol (2009) 1.12
Corticotropin-releasing hormone stimulates NF-kappaB in human epidermal keratinocytes. J Endocrinol (2004) 1.10
Synthesis and photo-conversion of androsta- and pregna-5,7-dienes to vitamin D3-like derivatives. Photochem Photobiol Sci (2008) 1.09
UV light and MSH receptors. Ann N Y Acad Sci (1999) 1.09
Expression of hypothalamic-pituitary-thyroid axis related genes in the human skin. J Invest Dermatol (2002) 1.09
Pleiotropic effects of corticotropin releasing hormone on normal human skin keratinocytes. In Vitro Cell Dev Biol Anim (2001) 1.07
Characterization of corticotropin-releasing hormone (CRH) in human skin. J Clin Endocrinol Metab (1998) 1.06
Ultraviolet B stimulates production of corticotropin releasing factor (CRF) by human melanocytes. FEBS Lett (1996) 1.06
Proopiomelanocortin expression in the skin during induced hair growth in mice. Experientia (1992) 1.05
Conversion of L-tryptophan to serotonin and melatonin in human melanoma cells. FEBS Lett (2002) 1.05
On the potential role of proopiomelanocortin in skin physiology and pathology. Mol Cell Endocrinol (1993) 1.04
A role of melatonin in neuroectodermal-mesodermal interactions: the hair follicle synthesizes melatonin and expresses functional melatonin receptors. FASEB J (2005) 1.03
Melatonin as a major skin protectant: from free radical scavenging to DNA damage repair. Exp Dermatol (2008) 1.03
Proopiomelanocortin, corticotropin releasing hormone and corticotropin releasing hormone receptor genes are expressed in human skin. FEBS Lett (1995) 1.02
The skin as a mirror of the soul: exploring the possible roles of serotonin. Exp Dermatol (2007) 1.02
Oncostatic effects of the indole melatonin and expression of its cytosolic and nuclear receptors in cultured human melanoma cell lines. Int J Oncol (2006) 1.02
Melatonin increases survival of HaCaT keratinocytes by suppressing UV-induced apoptosis. J Pineal Res (2006) 1.01
The skin produces urocortin. J Clin Endocrinol Metab (2000) 1.01
The role of corticotropin-releasing hormone in immune-mediated cutaneous inflammatory disease. Exp Dermatol (2006) 1.01
Cultured human dermal fibroblasts do produce cortisol. J Invest Dermatol (2006) 1.00
CRF1 receptor splicing in epidermal keratinocytes: potential biological role and environmental regulations. J Cell Physiol (2009) 1.00
Melatonin inhibits proliferation and melanogenesis in rodent melanoma cells. Exp Cell Res (1993) 0.99
Corticotropin-releasing hormone affects cytokine production in human HaCaT keratinocytes. Life Sci (2002) 0.99
Tryptophan hydroxylase expression in human skin cells. Biochim Biophys Acta (2003) 0.98
Emerging role of alternative splicing of CRF1 receptor in CRF signaling. Acta Biochim Pol (2010) 0.97
Liquid chromatography-mass spectrometry detection of corticotropin-releasing hormone and proopiomelanocortin-derived peptides in human skin. J Clin Endocrinol Metab (2000) 0.96
CRH inhibits NF-kappa B signaling in human melanocytes. Peptides (2006) 0.96
Gas chromatography/mass spectrometry characterization of corticosteroid metabolism in human immortalized keratinocytes. J Invest Dermatol (2002) 0.95
Thyrotropin releasing hormone (TRH): a new player in human hair-growth control. FASEB J (2009) 0.95
Corticotropin releasing factor receptor type 1: molecular cloning and investigation of alternative splicing in the hamster skin. J Invest Dermatol (2002) 0.95
Metabolism of serotonin to N-acetylserotonin, melatonin, and 5-methoxytryptamine in hamster skin culture. J Biol Chem (1996) 0.95
Thyroid-stimulating hormone, a novel, locally produced modulator of human epidermal functions, is regulated by thyrotropin-releasing hormone and thyroid hormones. Endocrinology (2010) 0.94
Melatonin maintains mitochondrial membrane potential and attenuates activation of initiator (casp-9) and effector caspases (casp-3/casp-7) and PARP in UVR-exposed HaCaT keratinocytes. J Pineal Res (2007) 0.92
Are L-tyrosine and L-dopa hormone-like bioregulators? J Theor Biol (1990) 0.92
Corticotropin-releasing hormone inhibits nuclear factor-kappaB pathway in human HaCaT keratinocytes. J Invest Dermatol (2003) 0.92
Modulation of the human hair follicle pigmentary unit by corticotropin-releasing hormone and urocortin peptides. FASEB J (2006) 0.90
Corticotropin-releasing hormone triggers differentiation in HaCaT keratinocytes. Br J Dermatol (2005) 0.90
Identification and characterization of two isozymic forms of arylamine N-acetyltransferase in Syrian hamster skin. J Invest Dermatol (1993) 0.90
The human hair bulb is a source and target of CRH. J Invest Dermatol (2004) 0.89
Murine skin as a target for melatonin bioregulation. Exp Dermatol (1994) 0.89
Towards defining receptors for L-tyrosine and L-dopa. Mol Cell Endocrinol (1994) 0.88
Expression of proopiomelanocortin (POMC)-derived melanocyte-stimulating hormone (MSH) and adrenocorticotropic hormone (ACTH) peptides in skin of basal cell carcinoma patients. Hum Pathol (1999) 0.88
Expression of genes coding melatonin and serotonin receptors in rodent skin. Biochim Biophys Acta (2004) 0.84
20-Hydroxyvitamin D3, a product of vitamin D3 hydroxylation by cytochrome P450scc, stimulates keratinocyte differentiation. J Invest Dermatol (2008) 1.91
20-Hydroxycholecalciferol, product of vitamin D3 hydroxylation by P450scc, decreases NF-kappaB activity by increasing IkappaB alpha levels in human keratinocytes. PLoS One (2009) 1.65
Melanogenesis affects overall and disease-free survival in patients with stage III and IV melanoma. Hum Pathol (2013) 1.50
Melatonin membrane receptors in peripheral tissues: distribution and functions. Mol Cell Endocrinol (2012) 1.47
20,23-dihydroxyvitamin D3, novel P450scc product, stimulates differentiation and inhibits proliferation and NF-kappaB activity in human keratinocytes. J Cell Physiol (2010) 1.44
Expression of vitamin D receptor decreases during progression of pigmented skin lesions. Hum Pathol (2011) 1.38
Inhibition of melanogenesis as a radiation sensitizer for melanoma therapy. Int J Cancer (2008) 1.33
Photo-conversion of two epimers (20R and 20S) of pregna-5,7-diene-3beta, 17alpha, 20-triol and their bioactivity in melanoma cells. Steroids (2008) 1.24
Cytochromes p450 and skin cancer: role of local endocrine pathways. Anticancer Agents Med Chem (2014) 1.20
Corticotropin-releasing hormone induces keratinocyte differentiation in the adult human epidermis. J Cell Physiol (2005) 1.14
Corticotropin-releasing hormone stimulates NF-kappaB in human epidermal keratinocytes. J Endocrinol (2004) 1.10
Expression of the vitamin D-activating enzyme 1α-hydroxylase (CYP27B1) decreases during melanoma progression. Hum Pathol (2012) 1.09
Synthesis and photo-conversion of androsta- and pregna-5,7-dienes to vitamin D3-like derivatives. Photochem Photobiol Sci (2008) 1.09
Vitamin D analogs 17,20S(OH)2pD and 17,20R(OH)2pD are noncalcemic and exhibit antifibrotic activity. J Invest Dermatol (2011) 1.08
The role of melanin pigment in melanoma. Exp Dermatol (2015) 1.03
Metabolism of melatonin and biological activity of intermediates of melatoninergic pathway in human skin cells. FASEB J (2013) 1.02
Synthesis and photochemical transformation of 3β,21-dihydroxypregna-5,7-dien-20-one to novel secosteroids that show anti-melanoma activity. Steroids (2010) 1.01
CRF1 receptor splicing in epidermal keratinocytes: potential biological role and environmental regulations. J Cell Physiol (2009) 1.00
Correlation between secosteroid-induced vitamin D receptor activity in melanoma cells and computer-modeled receptor binding strength. Mol Cell Endocrinol (2012) 0.99
Expression of molecular equivalent of hypothalamic-pituitary-adrenal axis in adult retinal pigment epithelium. J Endocrinol (2007) 0.98
Genetic variation of the cutaneous HPA axis: an analysis of UVB-induced differential responses. Gene (2013) 0.98
Structure-activity relationship studies of arylthiazolidine amides as selective cytotoxic agents for melanoma. Anticancer Res (2007) 0.97
Emerging role of alternative splicing of CRF1 receptor in CRF signaling. Acta Biochim Pol (2010) 0.97
Novel vitamin D photoproducts and their precursors in the skin. Dermatoendocrinol (2013) 0.96
CRH inhibits NF-kappa B signaling in human melanocytes. Peptides (2006) 0.96
Novel vitamin D analogs as potential therapeutics: metabolism, toxicity profiling, and antiproliferative activity. Anticancer Res (2014) 0.95
New vitamin D analogs as potential therapeutics in melanoma. Expert Rev Anticancer Ther (2012) 0.94
CRH mediates inflammation induced by lipopolysaccharide in human adult epidermal keratinocytes. J Invest Dermatol (2006) 0.94
Design, synthesis, and biological action of 20R-hydroxyvitamin D3. J Med Chem (2012) 0.93
Hydroxylation of CYP11A1-derived products of vitamin D3 metabolism by human and mouse CYP27B1. Drug Metab Dispos (2013) 0.92
Corticotropin-releasing hormone inhibits nuclear factor-kappaB pathway in human HaCaT keratinocytes. J Invest Dermatol (2003) 0.92
The role of constitutively activated STAT3 in B16 melanoma cells. Int J Interferon Cytokine Mediat Res (2010) 0.91
Metabolism of cholesterol, vitamin D3 and 20-hydroxyvitamin D3 incorporated into phospholipid vesicles by human CYP27A1. J Steroid Biochem Mol Biol (2011) 0.91
Human cytochrome P450scc (CYP11A1) catalyzes epoxide formation with ergosterol. Drug Metab Dispos (2011) 0.90
Synergistic activation of steroidogenic acute regulatory protein expression and steroid biosynthesis by retinoids: involvement of cAMP/PKA signaling. Endocrinology (2013) 0.88
Human female hair follicles are a direct, nonclassical target for thyroid-stimulating hormone. J Invest Dermatol (2008) 0.85
High-resolution magic angle spinning nuclear magnetic resonance analysis of metabolic changes in melanoma cells after induction of melanogenesis. Anal Biochem (2008) 0.84
The melatonin-producing system is fully functional in retinal pigment epithelium (ARPE-19). Mol Cell Endocrinol (2009) 0.83
Transplantable melanomas in gerbils (Meriones unguiculatus). II: melanogenesis. Exp Dermatol (2003) 0.80
Commentary on the practical guide for the study of sebaceous glands. Exp Dermatol (2013) 0.78
N1-Acetyl-5-Methoxykynuramine (AMK) is produced in the human epidermis and shows antiproliferative effects. Endocrinology (2015) 0.77
Is Mc1r an important regulator of non-pigmentary responses to UV radiation? Exp Dermatol (2013) 0.77
Effects of in utero exposure of C57BL/6J mice to 2,3,7,8-tetrachlorodibenzo-p-dioxin on epidermal permeability barrier development and function. Environ Health Perspect (2014) 0.77
Targeting ALDH1A1 to treat pigmentary disorders. Exp Dermatol (2013) 0.75